Trials / Conditions / t(9;22)
t(9;22)
3 registered clinical trials studyying t(9;22) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Rela NCT03576547 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positi NCT03263572 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive NCT00390793 | M.D. Anderson Cancer Center | Phase 2 |